Antimicrobial lenses displaying extended efficacy, processes to prepare them and methods of their use

• US 20040151755A1
• Filed: 11/18/2003
• Published: 08/05/2004
• Est. Priority Date: 12/21/2000
• Status: Abandoned Application

• Current Assignee: Johnson & Johnson Vision Care Incorporated (Johnson & Johnson)
• Original Assignee: Johnson & Johnson Vision Care Incorporated (Johnson & Johnson)
• Inventors: Riederer, Donald E., Vanderlaan, Douglas, Neely, Frank, Rathore, Osman, Zanini, Diana, Andersson, Ann-Margret
• Application Number:
  US10/715,745
• Publication Number:
  US 20040151755A1
• Time in Patent Office: Days
• US Class Current: 424/429
• CPC Class Codes: A61L 12/088 Heavy metals
• CPC Class Codes: G02B 1/043 Contact lenses

Abstract

This invention relates to antimicrobial ophthalmic devices containing silver releasing compounds and methods for their production. The antimicrobial lenses of the present invention have percent haze of less than about 200% and have a release rate constant, calculated using a first order kinetics equation of up to about 1 days⁻¹ and an initial silver concentration of at least about 10 ppm.

Claims

1. An ophthalmic device comprising a polymer and ionized silver in an initial concentration of at least about 10 ppm, wherein said ophthalmic device has a haze of less than about 200% and said silver releases from said ophthalmic device during use at rate with a rate constant, calculated using a first order kinetics equation, of up to about 1 days⁻

1.

2. The ophthalmic device of claim 1 wherein said rate constant is between about 0.001 and about 0.5 days⁻

1.

3. The ophthalmic device of claim 1 wherein said rate constant is between about 0.01 and about 0.3 days⁻

1.

4. The ophthalmic device of claim 1 wherein said rate constant is between about 0.001 and about 0.2 days⁻

1.

5. The ophthalmic device of claim 1 wherein said initial silver concentration is between about 10 and about 10,000 ppm.

6. The ophthalmic device of claim 1 wherein said initial silver concentration is between about 25 and about 5,000 ppm.

7. The ophthalmic device of claim 1 wherein said initial silver concentration is between about 50 and about 3,000 ppm.

8. The ophthalmic device of claim 1 wherein said initial silver concentration and rate constant are sufficient to provide an at least about 50% reduction in microbial activity over said device'"'"'s use.

9. The ophthalmic device of claim 1 wherein said ophthalmic device is a contact lens.

10. The contact lens of claim 9 wherein said initial silver concentration and rate constant are maintained below amounts which would cause argyria.

11. The contact lens of claim 9 wherein after about a day said silver releases from said ophthalmic device during use at a rate with a rate constant, calculated using a first order kinetics equation of up to about 1 day⁻

1.

12. The contact lens of claim 9 is substantially free from visible haze.

13. The contact lens of claim 9 having less than 150% haze.

14. The contact lens of claim 9 having less than 100% haze.

15. The ophthalmic device of claim 1 wherein said polymer further comprises a ligand to which said silver is releasably bound.

16. The ophthalmic device of claim 1 wherein said ophthalmic device is a contact lens and said initial silver concentration and rate constant are sufficient to provide an at least about 50% reduction in microbial activity over said device'"'"'s use.

17. The contact lens of claim 9 wherein said use is continuous wear for at least 14 days.

18. The contact lens of claim 9 wherein said use is continuous wear for at least 30 days.

19. The contact lens of claim 9 wherein said silver releases from said contact lens during use in an amount sufficient to provide at least a 70% reduction in bacterial activity over said use.

20. The contact lens of claim 9 wherein said silver releases from said contact lens during use in an amount sufficient to provide at least a 90% reduction in bacterial activity over said use.

21. The ophthalmic device of claim 1 wherein said silver releasing compound has a molar solubility of silver ion in pure water of about 25°

C. of about 2.0×

10<sup>−

30</sup> moles/L to about 2 moles/L.

22. The ophthalmic device of claim 1 wherein said silver releasing compound has a molar solubility of silver ion in pure water of greater than about 2.0×

10<sup>−

17</sup> moles/L.

23. The contact lens of claim 9 wherein said polymer comprises a silicone hydrogel.

24. The contact lens of claim 9 wherein said silicone hydrogel is selected from the group consisting of senofilcon A, galyfilcon A, lotrafilcon A and balafilcon A.

25. The ophthalmic device of claim 1 wherein said polymer is formed from a reaction mixture comprising at least one silicone-containing component.

26. The ophthalmic device of claim 1 wherein said reaction mixture further comprises at least one hydrophilic component.

27. The ophthalmic device of claim 1 wherein said ophthalmic device is coated.

28. The contact lens of claim 9 wherein said polymer is formed from a reaction mixture comprising at least one silicone-containing component.

29. The contact lens of claim 9 wherein said reaction mixture further comprises at least one hydrophilic component.

30. The contact lens of claim 9 wherein said ophthalmic device is coated.

31. The contact lens of claim 9, wherein said lens displays a reduction in microbial colonization of at least about 2 log after two days.

32. The contact lens of claim 9, wherein said lens displays a reduction in microbial colonization of at least about 1 log after two days.

33. The contact lens of claim 9, wherein said lens displays a reduction in microbial colonization of at least about 2 log after 10 days.

34. The contact lens of claim 9, wherein said lens displays a reduction in microbial colonization of at least about 1 log after 10 days.

35. The contact lens of claim 9, wherein said lens displays a reduction in microbial colonization of at least about 05 log after 30 days.